Point-of-care monitoring of the host-pathogen interaction during infection
Ended Definitive Contract Awarded Last action
- Contract number
- IND17PC00071
- Awardee
-
Inflammatix, Inc. UEI WK9MLMSHBVL3
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $999,923
Award facts
- Opportunity
-
- 162PHASEII Solicitation number
- Contract value 100% obligated
- $999,923.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Advanced Research Projects Agency Department of Defense
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 25 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94112, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | $559,083 | |
| Original award | $440,840 |
About this award
This is a $999,923 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business in Sunnyvale, California. The contract is for the development of point-of-care diagnostic solutions to monitor the host-pathogen interaction during infection. Inflammatix has been awarded over $29 million in federal contracts and grants from agencies like the Department of Health and Human Services and the National Institutes of Health to support the development of diagnostic cartridges and host-response prognostic tools for conditions such as sepsis, myocardial infarction, and inflammatory bowel disease. The contract has a firm fixed price and a completion date of February 19, 2019.
Quick answers
Who was awarded contract IND17PC00071?
IND17PC00071 was awarded to Inflammatix, Inc. by Interior Business Center (Office of Policy Management and Budget) on January 20, 2017.
How much is contract IND17PC00071 worth?
The government has obligated $999,923 on IND17PC00071.
Which agency awarded contract IND17PC00071?
Interior Business Center (Office of Policy Management and Budget) awarded IND17PC00071, with funding from Defense Advanced Research Projects Agency (Department of Defense).
Was contract IND17PC00071 competed?
The extent of competition for IND17PC00071 was full and open competition after exclusion of sources. The government received 25 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award